ABSTRACT
The objective of this study was to examine temporal variations in synovial fluid composition and lubrication following articular fracture. Post-traumatic osteoarthritis (PTOA) was induced by creating an osteochondral fracture in the middle carpal joint of four horses while the contralateral limb served as a sham-operated control. Horses were exercised on a high-speed treadmill, and synovial fluid was collected pre-operatively and at serial timepoints until 75 days post-operatively. Lubricin and hyaluronic acid (HA) concentrations were measured using sandwich ELISAs, and the molecular weight distribution of HA was analyzed via gel electrophoresis. Synovial fluid viscosity and cartilage friction coefficients across all modes of lubrication were measured on days 0, 19, 33, and 61 using a commercial rheometer and a custom tribometer, respectively. HA concentrations were significantly decreased post-operatively, and high molecular weight HA (>6.1MDa) did not recover to pre-operative values by the study termination at day 75. Lubricin concentrations increased after surgery to a greater extent in the OA as compared to sham-operated limbs. Viscosity was significantly reduced after surgery. While boundary and elastoviscous mode friction coefficients did not vary, the transition number, representing the shift between these modes, was lower. Although more pronounced in the OA limbs, similar derangements in HA, HA molecular weight distribution, viscosity, and transition number were observed in the sham-operated limbs, which may be explained by synovial fluid washout during arthroscopy. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res.
Subject(s)
Carpal Joints/injuries , Glycoproteins/metabolism , Hyaluronic Acid/metabolism , Osteoarthritis/etiology , Synovial Fluid/metabolism , Animals , Carpal Joints/metabolism , Disease Models, Animal , Female , Horses , Male , Osteoarthritis/metabolismABSTRACT
OBJECTIVE: Gene therapy holds great promise for the treatment of osteoarthritis (OA) because a single intraarticular injection can lead to long-term expression of therapeutic proteins within the joint. This study was undertaken to investigate the use of a helper-dependent adenovirus (HDAd)-mediated intraarticular gene therapy approach for long-term expression of interleukin-1 receptor antagonist (IL-1Ra) as sustained symptomatic and disease-modifying therapy for OA. METHODS: In mouse models of OA, efficacy of HDAd-IL-1Ra was evaluated by histologic analysis, micro-computed tomography (micro-CT), and hot plate analysis. In a horse OA model, safety and efficacy of HDAd-IL-1Ra were evaluated by blood chemistry, analyses of synovial fluid, synovial membrane, and cartilage, and gross pathology and lameness assessments. RESULTS: In skeletally immature mice, HDAd-IL-1Ra prevented development of cartilage damage, osteophytes, and synovitis. In skeletally immature and mature mice, treatment with HDAd-interleukin-1 receptor antagonist post-OA induction resulted in improved-albeit not significantly-cartilage status assessed histologically and significantly increased cartilage volume, cartilage surface, and bone surface covered by cartilage as assessed by micro-CT. Fewer osteophytes were observed in HDAd-IL-1Ra-treated skeletally immature mice. Synovitis was not affected in skeletally immature or mature mice. HDAd-IL-1Ra protected against disease-induced thermal hyperalgesia in skeletally mature mice. In the horse OA model, HDAd-IL-1Ra therapy significantly improved lameness parameters, indicating efficient symptomatic treatment. Moreover, macroscopically and histologically assessed cartilage and synovial membrane parameters were significantly improved, suggesting disease-modifying efficacy. CONCLUSION: These data from OA models in small and large animals demonstrated safe symptomatic and disease-modifying treatment with an HDAd-expressing IL-1Ra. Furthermore, this study establishes HDAd as a vector for joint gene therapy.
Subject(s)
Arthritis, Experimental/therapy , Cartilage, Articular/pathology , Genetic Therapy/methods , Interleukin 1 Receptor Antagonist Protein/genetics , Osteoarthritis/therapy , Osteophyte/pathology , Stifle/pathology , Synovitis/pathology , Adenoviridae , Animals , Carpal Joints/diagnostic imaging , Carpal Joints/metabolism , Carpal Joints/pathology , Cartilage, Articular/diagnostic imaging , Cartilage, Articular/metabolism , Disease Models, Animal , Forelimb , Horses , Interleukin 1 Receptor Antagonist Protein/metabolism , Ligaments, Articular/surgery , Mice , Osteoarthritis/metabolism , Osteophyte/diagnostic imaging , Osteophyte/metabolism , Stifle/diagnostic imaging , Stifle/metabolism , Synovial Fluid/metabolism , Synovial Membrane/metabolism , Synovitis/diagnostic imaging , Synovitis/metabolism , X-Ray MicrotomographyABSTRACT
Regional limb perfusion (RLP) in horses has proven to be a simple and effective technique for the treatment of synovial and musculoskeletal infections in the distal portion of the limbs. The ideal tourniquet time needed to achieve therapeutic synovial concentrations remains unknown. The pharmacokinetic effects of general anesthesia (GA) versus standing sedation (SS) RLP on synovial amikacin concentrations are not completely understood. This study investigated the pharmacokinetic effects of RLP under general anesthesia (GA) versus standing sedation (SS) on synovial amikacin concentration following 20 or 30 min tourniquet time. Using 1 g of amikacin RLP was performed in two groups of six horses (GA and SS). A pneumatic tourniquet was applied proximal to the carpus and maintained for 20 or 30 min. Two weeks later, the opposite treatment (20 or 30 min) was randomly performed in the opposite limb of horses in each group (GA and SS). Synovial fluid samples were collected from the metacarpophalangeal (MCP) and radiocarpal (RC) joints. Amikacin was quantified by a fluorescence polarization immunoassay. Regardless of the group, no significant difference in the synovial amikacin concentrations was noted between 20 and 30 min RLP. Mean synovial concentrations of amikacin in the standing sedated horses were significantly higher in the MCP joint at 30 min (P = 0.003) compared to horses under general anesthesia. No significant difference was noted for the RC joint.
Subject(s)
Amikacin/pharmacokinetics , Anti-Bacterial Agents/pharmacokinetics , Carpal Joints/metabolism , Metacarpophalangeal Joint/metabolism , Synovial Fluid/chemistry , Tourniquets/veterinary , Administration, Intravenous/veterinary , Amikacin/administration & dosage , Animals , Anti-Bacterial Agents/administration & dosage , Female , Forelimb/metabolism , Horses , Male , Perfusion/veterinary , Random Allocation , Time FactorsABSTRACT
A gene therapeutic approach to treat osteoarthritis (OA) appears to be on the horizon for millions of people who suffer from this disease. Previously we described optimization of a scAAVIL-1ra gene therapeutic vector and initially tested this in an equine model verifying long-term intrasynovial IL-1ra protein at therapeutic levels. Using this vector, we carried out a dosing trial in six horses to verify protein levels and establish a dose that would express relevant levels of therapeutic protein for extended periods of time (8 months). A novel arthroscopic procedure used to detect green fluorescence protein (GFP) fluorescence intrasynovially confirmed successful transduction of the scAAVGFP vector in both the synovial and cartilage tissues. No evidence of intra-articular toxicity was detected. Immune responses to vector revealed development of neutralizing antibodies (Nabs) within 2 weeks of administration, which persisted for the duration of the study but did not lower protein expression intra-articularly. Re-dosing with a different serotype to attain therapeutic levels of protein confirmed establishment of successful transduction. This is the first study in an equine model to establish a dosing/redosing protocol, as well as examine the Nab response to capsid and supports further clinical investigation to determine the clinical efficacy of scAAVIL-1ra to treat OA.
Subject(s)
Gene Expression/immunology , Genetic Vectors/administration & dosage , Interleukin 1 Receptor Antagonist Protein/therapeutic use , Osteoarthritis/immunology , Osteoarthritis/therapy , Animals , Antibodies, Neutralizing/metabolism , Carpal Joints/immunology , Carpal Joints/metabolism , Carpal Joints/pathology , Cartilage, Articular/metabolism , Disease Models, Animal , Dose-Response Relationship, Immunologic , Genetic Therapy , Genetic Vectors/immunology , Genetic Vectors/therapeutic use , Horses , Interleukin 1 Receptor Antagonist Protein/immunology , Interleukin 1 Receptor Antagonist Protein/metabolism , Osteoarthritis/genetics , Osteoarthritis/metabolism , Synovial Membrane/metabolismABSTRACT
Intra-articular injection of opioids provides analgesia in painful equine joints and µ-opioid receptors (MORs) have been demonstrated in equine synovial membranes. The aim of this study was to determine whether acute inflammatory conditions will lead to up-regulation of MOR in equine synovial membranes and whether anti-inflammatory treatment can prevent any such upregulation. In a two-period, blinded, placebo-controlled randomised cross-over design, lipopolysaccharide (LPS, 1.0 ng) was injected into the left or right middle carpal joint of seven healthy ponies. Arthroscopy and synovial membrane biopsy was performed under general anaesthesia at baseline, 48 h (T48) and 672 h (T672) after LPS injection, with ponies assigned to receive either phenylbutazone (PBZ 2.2mg/kg PO BID) or placebo from 2h post-LPS. Ponies were scored for pain and lameness. Repeated synovial fluid samples were obtained and the degree of synovitis scored both macroscopically and microscopically. The density and staining pattern of MOR-like protein in synovial membrane biopsies over the course of the synovitis with or without PBZ treatment was evaluated using immunohistochemical techniques. LPS injection consistently induced a severe transient synovitis. Pain and lameness were significantly attenuated by treatment with PBZ. Up-regulation of MOR-like protein in the inflamed equine synovial membrane could be demonstrated in the placebo treated animals, but not in the PBZ-treated animals overall, although there were no significant differences at any individual time-point between the two groups. It was concluded that acute inflammation will up-regulate MOR, while anti-inflammatory treatment will attenuate this response.
Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Horse Diseases/drug therapy , Lameness, Animal/drug therapy , Pain/veterinary , Phenylbutazone/therapeutic use , Receptors, Opioid, mu/metabolism , Synovial Membrane/metabolism , Synovitis/veterinary , Animals , Arthroscopy/veterinary , Blotting, Western/veterinary , Carpal Joints/metabolism , Carpal Joints/pathology , Cross-Over Studies , Escherichia coli/physiology , Horse Diseases/chemically induced , Horse Diseases/metabolism , Horses , Inflammation/chemically induced , Inflammation/drug therapy , Inflammation/metabolism , Inflammation/veterinary , Injections, Intra-Articular/veterinary , Lameness, Animal/chemically induced , Lameness, Animal/metabolism , Lipopolysaccharides/administration & dosage , Lipopolysaccharides/immunology , Locomotion/drug effects , Male , Pain/drug therapy , Synovial Fluid/metabolism , Synovitis/chemically induced , Synovitis/drug therapy , Synovitis/metabolism , Up-RegulationABSTRACT
This study was done after identifying animals with a twisted carpal joint in goat herd. These included a kid goat walking on its articulus carpii and a newborn goat with a stiff leg. Necropsies of the diseased goats revealed swollen carpal joints that were twisted backwards. Arthritis was observed during microscopic examination of the carpal joints. Very low levels of eosinophil, leucocyte, and lymphocyte cell infiltration were found in the central nervous system and meninges. Serum copper levels were significantly decreased in most of the animals. All of these results led us to diagnose the animals with swayback disease.
Subject(s)
Carpal Joints/pathology , Copper/deficiency , Goat Diseases/congenital , Joint Diseases/veterinary , Animals , Animals, Newborn , Carpal Joints/metabolism , Copper/blood , Copper/metabolism , Female , Goat Diseases/metabolism , Goat Diseases/pathology , Goats , Joint Diseases/congenital , Joint Diseases/metabolism , Joint Diseases/pathology , Male , PregnancyABSTRACT
OBJECTIVE: To determine the effects of exercise on the distribution and pharmacokinetics of technetium Tc 99m medronate ((99m)Tc-MDP) following intra-articular (IA) injection in horses. ANIMALS: 5 horses. PROCEDURES: 1 antebrachiocarpal joint (ACJ)/horse was assigned to the exercised group (n = 5), and the contralateral ACJ was evaluated in the nonexercised group (5) after a minimum washout period of 7 days. Following IA injection of (99m)Tc-MDP (148 MBq), blood and scintigraphic images of the carpus were obtained at 5, 10, 15, 20, 25, 30, 45, 60, 90, 120, 240, 360, 480, 600, 720, and 1,440 minutes. Plasma and scintigraphic radioactivity were determined over time, and pharmacokinetic parameters were generated via noncompartmental and compartmental analyses. Each horse was monitored via physical and lameness examination and ACJ synovial fluid analysis before injection and at days 1, 2, 3, and 7. RESULTS: Lameness was not observed. Mean ± SD synovial fluid WBC count increased at day 1 (exercised, 721 ± 234 cells/µL; nonexercised, 948 ± 223 cells/µL), but returned to baseline at days 3 and 7 Mean time to maximum plasma radioactivity was earlier in the exercised group (16.00 ± 2.35 minutes) than the nonexercised group (43.75 ± 3.64 minutes). Linear regression of the scintigraphic radioactivity-time curves revealed a greater negative slope in the exercised group within the first 25 minutes. There was no difference in absorption or elimination rate constants in a 2-compartment model. CONCLUSIONS AND CLINICAL RELEVANCE: IA injection of (99m)Tc-MDP was safe and effective for evaluating synovial solute distribution. Exercise significantly increased early transfer of (99m)Tc-MDP from the ACJ into plasma, although absorption and elimination rate constants were not affected. Exercise may affect synovial clearance and withdrawal times of medications administered IA.
Subject(s)
Horses/physiology , Physical Conditioning, Animal , Radiopharmaceuticals/pharmacokinetics , Synovial Fluid/metabolism , Technetium Tc 99m Medronate/pharmacokinetics , Animals , Carpal Joints/diagnostic imaging , Carpal Joints/metabolism , Carpus, Animal/diagnostic imaging , Carpus, Animal/metabolism , Cross-Over Studies , Female , Horse Diseases/chemically induced , Horse Diseases/diagnosis , Horse Diseases/diagnostic imaging , Image Processing, Computer-Assisted , Injections, Intra-Articular/veterinary , Lameness, Animal/chemically induced , Lameness, Animal/diagnosis , Lameness, Animal/diagnostic imaging , Models, Chemical , Radionuclide Imaging/veterinary , Radiopharmaceuticals/administration & dosage , Radiopharmaceuticals/blood , Synovial Fluid/diagnostic imaging , Technetium Tc 99m Medronate/administration & dosage , Technetium Tc 99m Medronate/bloodABSTRACT
This study was done after identifying animals with a twisted carpal joint in goat herd. These included a kid goat walking on its articulus carpii and a newborn goat with a stiff leg. Necropsies of the diseased goats revealed swollen carpal joints that were twisted backwards. Arthritis was observed during microscopic examination of the carpal joints. Very low levels of eosinophil, leucocyte, and lymphocyte cell infiltration were found in the central nervous system and meninges. Serum copper levels were significantly decreased in most of the animals. All of these results led us to diagnose the animals with swayback disease.
Subject(s)
Animals , Female , Male , Pregnancy , Animals, Newborn , Carpal Joints/metabolism , Copper/blood , Goat Diseases/congenital , Goats , Joint Diseases/congenitalABSTRACT
Interleukin-1 (IL-1) has pleiotropic effects in cartilage. The interferon-induced, double stranded RNA-activated protein kinase PKR that phosphorylates eukaryotic initiation factor 2 (eIF2) alpha has been implicated in cytokine effects in chondrocytes. A compound was recently identified that potently suppresses PKR autophosphorylation (IC50 approximately 200 etaM) and partially restores PKR-inhibited translation in a cell-free system with significant effect in the nanomolar range. The objectives of this study were to exploit this potent PKR inhibitor to assess whether PKR kinase activity is required for catabolic and proinflammatory effects of IL-1alpha in cartilage and to determine whether IL-1alpha causes an increase in eIF2alpha phosphorylation that is antagonized by the PKR inhibitor. Cartilage explants were incubated with the PKR inhibitor and IL-1alpha. Culture media were assessed for sulfated glycosaminoglycan as an indicator of proteoglycan degradation and for prostaglandin E(2). Cartilage extracts were analyzed by Western blot for cyclooxygenase-2 and phosphorylated signaling molecules. Nanomolar concentrations of the PKR inhibitor suppressed proteoglycan degradation and cyclooxygenase-2 accumulation in IL-1alpha-activated cartilage. The PKR inhibitor stimulated or inhibited PGE(2) production with a biphasic dose response relationship. IL-1alpha increased the phosphorylation of both PKR and eIF2alpha, and nanomolar concentrations of PKR inhibitor suppressed the IL-1alpha-induced changes in phosphorylation. The results strongly support PKR involvement in pathways activated by IL-1alpha in chondrocytes.
Subject(s)
Cartilage/drug effects , Chondrocytes/drug effects , Interleukin-1alpha/pharmacology , eIF-2 Kinase/metabolism , Animals , Blotting, Western , Carpal Joints/drug effects , Carpal Joints/metabolism , Cartilage/cytology , Cartilage/metabolism , Cattle , Chondrocytes/cytology , Chondrocytes/metabolism , Culture Media, Conditioned/analysis , Culture Media, Conditioned/chemistry , Cyclooxygenase 2/metabolism , Dithiothreitol/analogs & derivatives , Dithiothreitol/pharmacology , Dose-Response Relationship, Drug , Eukaryotic Initiation Factor-2/metabolism , Glycosaminoglycans/metabolism , Humans , Inflammation Mediators/metabolism , Phosphorylation/drug effects , Protein Kinase Inhibitors/pharmacology , Proteoglycans/metabolism , Sulfates/metabolism , Time Factors , eIF-2 Kinase/antagonists & inhibitorsABSTRACT
The carpal joints are common sites of traumatic arthritis and osteoarthritis (OA) in athletic horses. The pro-inflammatory cytokines interleukin (IL)-6 and tumour necrosis factor (TNF) may be of great importance in the development of intra-articular lesions. The aim of the present study was to investigate possible associations between synovial fluid levels of bioactive IL-6 and TNF and different types of joint lesions seen in traumatic arthritis and OA. Synovial fluid was collected from horses with carpal lameness immediately before arthroscopic surgery. Articular cartilage, synovial membranes and intra-articular ligaments were assessed macroscopically at arthroscopy. Synovial fluid levels of IL-6 and TNF were determined by bioassays, and the cytokine levels between different grades of morphologic changes in each type of assessed tissue were compared. The highest levels of IL-6 were detected in joints with chip fractures. All joints with chip fractures also showed some degree of synovitis. Tumour necrosis factor bioactivity was low and not associated with any joint lesion. Hence, TNF is not useful as a biomarker indicating a specific joint lesion in equine traumatic arthritis or OA. We conclude that a dramatic increase of IL-6 in synovial fluid indicates the presence of osteochondral fragmentation, although low or undetectable levels of IL-6 do not exclude chip fractures. The role of IL-6 in the disease process of osteochondral fragmentation needs further investigation.
Subject(s)
Carpal Joints/pathology , Horse Diseases/metabolism , Interleukin-6/metabolism , Synovial Fluid/immunology , Synovitis/veterinary , Tumor Necrosis Factor-alpha/metabolism , Animals , Arthroscopy/veterinary , Biomarkers , Carpal Joints/metabolism , Carpus, Animal/metabolism , Carpus, Animal/pathology , Fractures, Bone , Horse Diseases/immunology , Horse Diseases/pathology , Horses , Synovial Fluid/metabolism , Synovitis/immunology , Synovitis/metabolism , Synovitis/pathologyABSTRACT
The individual elements of the vertebrate skeleton are separated by three different types of joints, fibrous, cartilaginous and synovial joints. Synovial joint formation in the limbs is coupled to the formation of the prechondrogenic condensations, which precede the formation of the joint interzone. We are beginning to understand the signals involved in the formation of prechondrogenic condensations and the subsequent differentiation of cells within the condensations into chondrocytes. However, relatively little is known about the molecules and molecular pathways involved in induction of the early joint interzone and the subsequent formation of the synovial joints. Based on gain-of function studies Wnt-signalling, in particular the canonical pathway, has been implicated in the joint induction process. Here we provide genetic evidence from loss-of function analysis of embryos lacking either the central player of the canonical Wnt-pathway, beta-catenin, in the limb mesenchyme or the two ligands, Wnt9a and Wnt4, demonstrating that canonical Wnt-signalling plays an important role in suppressing the chondrogenic potential of cells in the joint thereby actively allowing joint formation. Furthermore our data show that the beta-catenin activity is not essential for the induction of molecular markers expressed in the joint interzone. Thus, suggesting that canonical Wnt-signalling is not required for the induction, but for the subsequent maintenance of the fate of the joint interzone cells.
Subject(s)
Joints/embryology , Proto-Oncogene Proteins/metabolism , Wnt Proteins/metabolism , beta Catenin/metabolism , Animals , Bone Morphogenetic Proteins/metabolism , Carpal Joints/anatomy & histology , Carpal Joints/embryology , Carpal Joints/metabolism , Cartilage/anatomy & histology , Cartilage/growth & development , Chick Embryo , Chondrocytes/metabolism , Growth Differentiation Factor 5 , Joints/abnormalities , Joints/growth & development , Mesoderm/metabolism , Mice , Mice, Knockout , Models, Biological , Proto-Oncogene Proteins/genetics , Signal Transduction , Tarsal Joints/anatomy & histology , Tarsal Joints/embryology , Wnt Proteins/genetics , Wnt4 Protein , beta Catenin/geneticsABSTRACT
BACKGROUND: We examined the effect of excessive stress on the production of basic fibroblast growth factor (bFGF) by bovine cartilage. METHODS: Bovine articular carpal bone was harvested and cut into 1 cm thick slices horizontally. Continuous compressive stress (0, 2, 20 MPa) was loaded on the cartilage of the carpal bone using a stainless-steel cylinder with a diameter of 8 mm for 1 h. The slices were cultured immediately after compression, and the supernatant of the culture medium was collected for bFGF and nitric oxide (NO) measurement. Interleukin-4 (IL-4) or N(G)-monoethyl-L: -arginine (L: -NMEA) was added to the culture medium in some experiments. RESULTS: Basic FGF production was significantly increased after 36 h of cultivation without mechanical stress (0.40 +/- 0.03 microg/ml). In contrast, the bFGF concentration was not increased by compressive stress of 20 MPa after 36 h of cultivation. An NO inhibitor, L: -NMEA, did not alter the effect of compressive stress on the production of bFGF. IL-4 reduced the production of bFGF by cartilage with or without mechanical stress. CONCLUSIONS: Excessive stress on cartilage inhibits the production of bFGF in an NO-independent manner, and IL-4 plays an important role in the reduction of bFGF.